Securities code: 002435 securities abbreviation: Changjiangrunfa Health Industry Co.Ltd(002435) Announcement No.: 2022-005 Changjiangrunfa Health Industry Co.Ltd(002435)
Announcement on subsidiaries' drugs passing the conformity evaluation
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
Changjiangrunfa Health Industry Co.Ltd(002435) (hereinafter referred to as "the company") received a notice from its wholly-owned subsidiary Hainan Hailing Chemical Pharmaceutical Co., Ltd. (hereinafter referred to as "Hailing pharmaceutical"), and hailing pharmaceutical received the notice of approval for supplementary drug application for cefazolin sodium for injection approved and issued by the State Drug Administration, The drug is approved to pass the quality and efficacy consistency evaluation of generic drugs (hereinafter referred to as "consistency evaluation"). The relevant information is hereby announced as follows:
1、 Basic information of drugs
1. Generic name of drug: cefazolin sodium for injection
2. Dosage form: injection
3. Specification: 0.5g, 1.0g
4. Drug manufacturer: Hainan Hailing Chemical Pharmaceutical Co., Ltd
5. Holder of listing license: Hainan Hailing Chemical Pharmaceutical Co., Ltd
6. Application content: consistency evaluation
7. Approval conclusion: after review, this product has passed the consistency evaluation of quality and efficacy of generic drugs.
2、 Drug related information
Cefazolin sodium is the first generation cephalosporin with wide antibacterial spectrum. It is suitable for the treatment of respiratory tract infection, urinary tract infection, skin and soft tissue infection, bone and joint infection, sepsis, infective endocarditis, hepatobiliary system infection, reproductive system infection and perioperative infection prevention caused by sensitive bacteria.
Effects of cefazolin sodium for injection on Staphylococcus β The infection caused by lactam mold strains, Streptococcus, Escherichia coli and Proteus mirabilis is effective. Clinically, it is widely used to prevent surgical infection, especially in biliary surgery, plastic surgery, heart and gynecological surgery.
3、 Impact on the company and risk tips
The consistency evaluation of cefazolin sodium for injection of Hailing pharmaceutical industry will be conducive to the future market sales of the drug and enhance the market competitiveness. Drug sales are easily affected by national policies, market environment and other factors, with great uncertainty. Please make careful decisions and pay attention to preventing investment risks.
It is hereby announced.
Changjiangrunfa Health Industry Co.Ltd(002435) board of directors January 22, 2022
